EMA/EC consultations 2016

• Submission of comments on Guideline on good pharmacovigilance practices (GVP) get_app
• Submission of comments on 'Draft points to consider on frailty: Evaluation instruments for baseline characterisation of clinical trial populations get_app
• Submission of comments on 'Draft guideline on clinical development of medicinal products intended for the treatment of pain’ get_app
• Criteria to be fulfilled by industry stakeholder organisations involved in European Medicines Agency (EMA) activities get_app
• Industry reponse to NIVEL study reports: PIL-S and PIL-BOX get_app
• Submission of comments on 'Scientific guidance on post-authorisation efficacy studies' get_app